Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
BMC Palliative Care
|
January 31, 2025
Cross-referencing French hematology teams' knowledge and perception of end-of-life situations: a national mixed-methods survey
Chloé Prod'homme, Côme Bommier, Laurène Fenwarth, et al.
Expert Opinion on Therapeutic Targets
|
April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Fanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Bulletin Du Cancer
|
October 28, 2022
[Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC]
Valérie Coiteux, Laurène Fenwarth, Nicolas Duployez, et al.
BMJ Supportive & Palliative Care
|
March 27, 2020
Clinical research in cancer palliative care: a metaresearch analysis
Marie Vinches, Anouk Neven, Laurène Fenwarth, et al.
International Journal of Molecular Sciences
|
August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
Laurène Fenwarth, Elise Fournier, Meyling Cheok, et al.
Cancer Medicine
|
March 20, 2024
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era
Alexandre Iat, Michael Loschi, Sami Benachour, et al.
British Journal of Haematology
|
December 19, 2025
Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study
Augustin Boudry, Florian Chevillon, Alice Marceau-Renaut, et al.
BMC Bioinformatics
|
October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
British Journal of Haematology
|
September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia
Augustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Haematologica
|
December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use
Auriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
BMC Palliative Care
|
January 31, 2025
Cross-referencing French hematology teams' knowledge and perception of end-of-life situations: a national mixed-methods survey
Chloé Prod'homme, Côme Bommier, Laurène Fenwarth, et al.
Expert Opinion on Therapeutic Targets
|
April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implications
Fanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Bulletin Du Cancer
|
October 28, 2022
[Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC]
Valérie Coiteux, Laurène Fenwarth, Nicolas Duployez, et al.
BMJ Supportive & Palliative Care
|
March 27, 2020
Clinical research in cancer palliative care: a metaresearch analysis
Marie Vinches, Anouk Neven, Laurène Fenwarth, et al.
International Journal of Molecular Sciences
|
August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
Laurène Fenwarth, Elise Fournier, Meyling Cheok, et al.
Cancer Medicine
|
March 20, 2024
Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era
Alexandre Iat, Michael Loschi, Sami Benachour, et al.
British Journal of Haematology
|
December 19, 2025
Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot study
Augustin Boudry, Florian Chevillon, Alice Marceau-Renaut, et al.
BMC Bioinformatics
|
October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
British Journal of Haematology
|
September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia
Augustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Haematologica
|
December 10, 2020
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use
Auriane Lesieur, Xavier Thomas, Olivier Nibourel, et al.
Page
of 3